Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Myron S Kwong"'
Autor:
Jennifer Rachel Eads, Paul J. Catalano, George A. Fisher, Daniel Rubin, Andrei Iagaru, David S. Klimstra, Bhavana Konda, Myron S. Kwong, Jennifer A. Chan, Ana De Jesus-Acosta, Thorvardur Ragnar Halfdanarson, Walid Labib Shaib, Heloisa P. Soares, Sung Chul Hong, Terence Z. Wong, Peter J. O'Dwyer
Publikováno v:
Journal of Clinical Oncology. 40:4020-4020
4020 Background: High grade (G3) GEPNENs are a rare and heterogeneous disease entity for which there is little prospective treatment data. EP chemotherapy is the treatment standard but this may not be appropriate for all G3 GEPNEN pts. CAPTEM has dem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a0b61275322e964cb0a3b91086bf220
https://doi.org/10.1200/jco.2022.40.16_suppl.4020
https://doi.org/10.1200/jco.2022.40.16_suppl.4020
Publikováno v:
The Permanente Journal. 23
INTRODUCTION: Carcinoembryonic antigen (CEA) surveillance is recommended in patients with colorectal cancer for detection of potentially resectable metastases. In patients with appropriate symptoms, a highly increased CEA concentration (> 5 times the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de1b73741fa78327d8e12ff323402ea
https://doi.org/10.7812/tpp/18-022
https://doi.org/10.7812/tpp/18-022
Autor:
Douglas A. Ross, Daniel Zelterman, Gina G. Chung, Amanda Psyrri, Mohamad Kassar, Yung H. Son, Susan A. DiStasio, Barbara Burtness, Myron S. Kwong, Paul M. Weinberger, Clarence T. Sasaki, Bruce G. Haffty, L. Lekakis, Dennis L. Cooper, Lynn D. Wilson
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(15)
Purpose The poor functional outcome in patients with advanced head and neck squamous cell carcinoma (HNSCC) with surgery and radiation has led to alternative approaches to advanced disease. We conducted a phase II study of induction chemotherapy foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd97bc212096894ba333964b729027a
https://pubmed.ncbi.nlm.nih.gov/15284256
https://pubmed.ncbi.nlm.nih.gov/15284256
Publikováno v:
Oncology (Williston Park, N.Y.). 16(9 Suppl 9)
For more than 2 decades, combination chemotherapy has been the standard treatment for patients with small-cell lung cancer. Despite high initial response rates in both extensive- and limited-stage disease, long-term survival rates are only 10% to 20%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::89b229d680d1b659628618b7b2ee6ac0
https://pubmed.ncbi.nlm.nih.gov/12375799
https://pubmed.ncbi.nlm.nih.gov/12375799